Lymphoma

Top Story

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017

Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood cancers, thus limiting referrals, according to study results published in Cancer.

“Our findings are important as they shed light on factors that are potential barriers to hospice referrals,” Oreofe O. Odejide, MD, instructor of medicine at Harvard Medical School and physician at Dana-Farber Cancer Institute, said in a press release. “These findings can be employed to develop targeted interventions to address hospice underuse for patients with blood cancers.”

In the Journals Plus

Younger age linked to poorer survival from second cancers

May 22, 2017
Younger age at the time of a second primary malignant neoplasm diagnosis appeared linked to worse survival outcomes among cancer survivors, according to a retrospective…
In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in…

Leukemia & Lymphoma Society names chief medical officer

May 18, 2017
Gwen Nichols, MD, medical hematologist and oncologist in New York, became chief medical officer of the Leukemia & Lymphoma Society this spring. Nichols specializes…
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Video
Meeting News Coverage

VIDEO: Researchers aim for ‘home run’ with ibrutinib–palbociclib combination for mantle cell lymphoma

December 4, 2016
More »
Featured
Oncology Nursing Society Annual Congress

Oncology Nursing Society Annual Congress

CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
In the Journals Plus

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017
Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood…

In the Journals Plus

Younger age linked to poorer survival from second cancers

May 22, 2017
Younger age at the time of a second primary malignant neoplasm diagnosis appeared linked to worse survival outcomes among cancer survivors, according…

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society…

Leukemia & Lymphoma Society names chief medical officer

May 18, 2017
Gwen Nichols, MD, medical hematologist and oncologist in New York, became chief medical officer of the Leukemia & Lymphoma Society this spring…

FDA News

FDA grants priority review to copanlisib for follicular lymphoma

May 17, 2017
The FDA granted priority review to copanlisib for the treatment of patients with relapsed or refractory follicular lymphoma who received at least two…

In the Journals Plus

Survivors of Hodgkin lymphoma have increased risk for second cancer

May 16, 2017
Survivors of Hodgkin lymphoma — particularly those with a family history of cancer — faced an increased risk for developing a second

Meeting News

Chest irradiation confers elevated risk for CAD in Hodgkin lymphoma

May 10, 2017
Compared with matched controls, mediastinal irradiated Hodgkin lymphoma survivors have greater prevalence and severity of CAD, according to findings…

Point/Counter

Does chemotherapy still have a role in follicular lymphoma treatment?

HemOnc Today, May 10, 2017
POINT Follicular lymphoma is an indolent disease that has a heterogeneous presentation at diagnosis. Some patients present with a very low burden of…

Cover Story

Identification of prognostic markers remains ‘holy grail’ in follicular lymphoma research

HemOnc Today, May 10, 2017
Approximately 2% of Americans will be diagnosed with non-Hodgkin lymphoma during their lifetimes, according to NCI statistics. Follicular lymphoma…

Perlmutter Cancer Center names program leader

May 4, 2017
Ahmad Samer Al-Homsi, MD, MBA, will lead a new bone marrow transplantation program designed to treat blood cancers at NYU Langone’s Perlmutter…

More Headlines »
Advertisement
Advertisement